Back
Check Point Software Technologies Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
59
CHKP
Check Point Software Technologies
Last Price:
205.63
Seasonality Move:
17.46%
Sell
50
DRUG
Bright Minds Biosciences
Last Price:
73.20
Seasonality Move:
-16.97%
Buy
59
Check Point Software Technologies (CHKP)
is a Buy
Is Check Point Software Technologies a Buy, Sell or Hold?
- The current Check Point Software Technologies [CHKP] share price is $205.88. The Score for CHKP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CHKP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
- The current Bright Minds Biosciences [DRUG] share price is $28.80. The Score for DRUG is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CHKP Stock Price Chart
What is Check Point Software Technologies's stock price today?
-
The Check Point Software Technologies share price today is $205.88
The current trend is moderately bullish and CHKP is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $28.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
CHKP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.7 | Buy |
Relative Strength Index (14 RSI): | 66.23 | Buy |
Chaikin Money Flow: | -484708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (189.78 - 202.74) | Buy |
Bollinger Bands (100): | (162.49 - 194.49) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.5 | Buy |
Relative Strength Index (14 RSI): | 77.84 | Buy |
Chaikin Money Flow: | 92732 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-4.96 - 12.54) | Buy |
Bollinger Bands (100): | (-2.76 - 6.3) | Buy |
CHKP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 203.97 | Buy |
20-day SMA: | 197.36 | Buy |
50-day SMA: | 191.78 | Buy |
200-day SMA: | 168.57 | Buy |
8-day EMA: | 204.1 | Buy |
20-day EMA: | 198.96 | Buy |
50-day EMA: | 191.52 | Buy |
200-day EMA: | 170.6 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.28 | Buy |
20-day SMA: | 4.42 | Buy |
50-day SMA: | 2.44 | Buy |
200-day SMA: | 1.64 | Buy |
8-day EMA: | 13.74 | Buy |
20-day EMA: | 7.01 | Buy |
50-day EMA: | 3.65 | Buy |
200-day EMA: | 2.03 | Buy |
Check Point Software Technologies Earnings Growth & CHKP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.79 per share, and an increase next year of $0.96 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Check Point Software Technologies Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |